Literature DB >> 30286446

Bronchoscopic Lung Volume Reduction Treatment Using Endobronchial Valves for Emphysema: Emerging Questions.

Jorine E Hartman1,2, Lowie E G W Vanfleteren3,4,5, Eva M van Rikxoort6, Dirk-Jan Slebos7,8.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30286446      PMCID： PMC6390450          DOI： 10.1159/000491675

Source DB:  PubMed          Journal:  Respiration        ISSN： 0025-7931            Impact factor:   3.580


× No keyword cloud information.
  8 in total

1.  One-Year Follow-Up after Endobronchial Valve Treatment in Patients with Emphysema without Collateral Ventilation Treated in the STELVIO Trial.

Authors:  Karin Klooster; Jorine E Hartman; Nick H T Ten Hacken; Dirk-Jan Slebos
Journal:  Respiration       Date:  2016-12-15       Impact factor: 3.580

2.  Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study.

Authors:  Arschang Valipour; Dirk-Jan Slebos; Felix Herth; Kaid Darwiche; Manfred Wagner; Joachim H Ficker; Christoph Petermann; Ralf-Harto Hubner; Franz Stanzel; Ralf Eberhardt
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

3.  Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial.

Authors:  Claire Davey; Zaid Zoumot; Simon Jordan; William H McNulty; Dennis H Carr; Matthew D Hind; David M Hansell; Michael B Rubens; Winston Banya; Michael I Polkey; Pallav L Shah; Nicholas S Hopkinson
Journal:  Lancet       Date:  2015-06-23       Impact factor: 79.321

4.  Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation.

Authors:  Karin Klooster; Nick H T ten Hacken; Jorine E Hartman; Huib A M Kerstjens; Eva M van Rikxoort; Dirk-Jan Slebos
Journal:  N Engl J Med       Date:  2015-12-10       Impact factor: 91.245

5.  Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.

Authors:  Lowie E G W Vanfleteren; Martijn A Spruit; Miriam Groenen; Swetlana Gaffron; Vanessa P M van Empel; Piet L B Bruijnzeel; Erica P A Rutten; Jos Op 't Roodt; Emiel F M Wouters; Frits M E Franssen
Journal:  Am J Respir Crit Care Med       Date:  2013-04-01       Impact factor: 21.405

6.  A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM).

Authors:  Samuel V Kemp; Dirk-Jan Slebos; Alan Kirk; Malgorzata Kornaszewska; Kris Carron; Lars Ek; Gustav Broman; Gunnar Hillerdal; Herve Mal; Christophe Pison; Amandine Briault; Nicola Downer; Kaid Darwiche; Jagan Rao; Ralf-Harto Hübner; Christof Ruwwe-Glosenkamp; Valéry Trosini-Desert; Ralf Eberhardt; Felix J Herth; Eric Derom; Thomas Malfait; Pallav L Shah; Justin L Garner; Nick H Ten Hacken; Hazem Fallouh; Sylvie Leroy; Charles H Marquette
Journal:  Am J Respir Crit Care Med       Date:  2017-12-15       Impact factor: 21.405

7.  Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial.

Authors:  Jens M Hohlfeld; Jens Vogel-Claussen; Heike Biller; Dominik Berliner; Korbinian Berschneider; Hanns-Christian Tillmann; Simone Hiltl; Johann Bauersachs; Tobias Welte
Journal:  Lancet Respir Med       Date:  2018-02-21       Impact factor: 30.700

8.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Authors:  Claus F Vogelmeier; Gerard J Criner; Fernando J Martínez; Antonio Anzueto; Peter J Barnes; Jean Bourbeau; Bartolome R Celli; Rongchang Chen; Marc Decramer; Leonardo M Fabbri; Peter Frith; David M G Halpin; M Victorina López Varela; Masaharu Nishimura; Nicolás Roche; Roberto Rodríguez-Roisin; Don D Sin; Dave Singh; Robert Stockley; Jørgen Vestbo; Jadwiga A Wedzicha; Alvar Agustí
Journal:  Arch Bronconeumol       Date:  2017-03-06       Impact factor: 4.872
  8 in total
  3 in total

1.  Protocol of a Randomized Controlled Study of the PneumRx Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema (ELEVATE).

Authors:  Felix J F Herth; Dirk-Jan Slebos; Pallav L Shah; Martin Hetzel; Gerald Schmid-Bindert; Adam S LaPrad; Gaëtan Deslée; Arschang Valipour
Journal:  Respiration       Date:  2019-11-19       Impact factor: 3.580

2.  Lung volume reduction in real clinical practice.

Authors:  Jorine E Hartman; Dirk-Jan Slebos
Journal:  ERJ Open Res       Date:  2021-06-07

3.  An Integrative Approach of the Fissure Completeness Score and Chartis Assessment in Endobronchial Valve Treatment for Emphysema.

Authors:  Karin Klooster; T David Koster; Christoph Ruwwe-Glösenkamp; Dorothea Theilig; Felix Doellinger; Jacopo Saccomanno; Huib A M Kerstjens; Dirk-Jan Slebos; Ralf-Harto Hübner
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.